Literature DB >> 22811041

Shattered and stitched chromosomes-chromothripsis and chromoanasynthesis-manifestations of a new chromosome crisis?

Christiaan Righolt1, Sabine Mai.   

Abstract

Chromothripsis (chromosome shattering) has been described as complex rearrangements affecting single chromosome(s) in one catastrophic event. The chromosomes would be "shattered" and "stitched together" during this event. This phenomenon is proposed to constitute the basis for complex chromosomal rearrangements seen in 2-3% of all cancers and in ∼ 25% of bone cancers. Here we discuss chromothripsis, the use of this term and the evidence presented to support a single catastrophic event that remodels the genome in one step. We discuss why care should be taken in using the term chromothripsis and what evidence is lacking to support its use while describing complex rearrangements.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22811041     DOI: 10.1002/gcc.21981

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Chromothripsis: breakage-fusion-bridge over and over again.

Authors:  Carlos Oscar Sánchez Sorzano; Alberto Pascual-Montano; Ainhoa Sánchez de Diego; Carlos Martínez-A; Karel H M van Wely
Journal:  Cell Cycle       Date:  2013-06-11       Impact factor: 4.534

2.  Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors.

Authors:  Xiumei Zhao; Yi-Jue Zhao; Qi Lin; Litian Yu; Zhigang Liu; Holly Lindsay; Mari Kogiso; Pulivarthi Rao; Xiao-Nan Li; Xinyan Lu
Journal:  Neuro Oncol       Date:  2014-12-23       Impact factor: 12.300

3.  Gene fusions by chromothripsis of chromosome 5q in the VCaP prostate cancer cell line.

Authors:  Inês Teles Alves; Saskia Hiltemann; Thomas Hartjes; Peter van der Spek; Andrew Stubbs; Jan Trapman; Guido Jenster
Journal:  Hum Genet       Date:  2013-04-25       Impact factor: 4.132

4.  Sugar and chromosome stability: clastogenic effects of sugars in vitamin B6-deficient cells.

Authors:  Antonio Marzio; Chiara Merigliano; Maurizio Gatti; Fiammetta Vernì
Journal:  PLoS Genet       Date:  2014-03-20       Impact factor: 5.917

5.  Defining the diverse spectrum of inversions, complex structural variation, and chromothripsis in the morbid human genome.

Authors:  Ryan L Collins; Harrison Brand; Claire E Redin; Carrie Hanscom; Caroline Antolik; Matthew R Stone; Joseph T Glessner; Tamara Mason; Giulia Pregno; Naghmeh Dorrani; Giorgia Mandrile; Daniela Giachino; Danielle Perrin; Cole Walsh; Michelle Cipicchio; Maura Costello; Alexei Stortchevoi; Joon-Yong An; Benjamin B Currall; Catarina M Seabra; Ashok Ragavendran; Lauren Margolin; Julian A Martinez-Agosto; Diane Lucente; Brynn Levy; Stephan J Sanders; Ronald J Wapner; Fabiola Quintero-Rivera; Wigard Kloosterman; Michael E Talkowski
Journal:  Genome Biol       Date:  2017-03-06       Impact factor: 13.583

Review 6.  Chromosomal Instability in Acute Myeloid Leukemia.

Authors:  Mateus de Oliveira Lisboa; Paulo Roberto Slud Brofman; Ana Teresa Schmid-Braz; Aline Rangel-Pozzo; Sabine Mai
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

7.  Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.

Authors:  Nadine Kaye Berry; Nicole L Bain; Anoop K Enjeti; Philip Rowlings
Journal:  J Clin Pathol       Date:  2013-08-22       Impact factor: 3.411

8.  The elusive evidence for chromothripsis.

Authors:  Marcus Kinsella; Anand Patel; Vineet Bafna
Journal:  Nucleic Acids Res       Date:  2014-06-17       Impact factor: 16.971

Review 9.  Cell death-based treatment of childhood cancer.

Authors:  Mike-Andrew Westhoff; Nicolas Marschall; Michael Grunert; Georg Karpel-Massler; Stefan Burdach; Klaus-Michael Debatin
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

10.  Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples.

Authors:  George Vasmatzis; Xue Wang; James B Smadbeck; Stephen J Murphy; Katherine B Geiersbach; Sarah H Johnson; Athanasios G Gaitatzes; Yan W Asmann; Farhad Kosari; Mitesh J Borad; Daniel J Serie; Sarah A McLaughlin; Jennifer M Kachergus; Brian M Necela; E Aubrey Thompson
Journal:  BMC Cancer       Date:  2018-07-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.